Document:

THIS
WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE BEEN AND WILL BE ISSUED WITHOUT REGISTRATION UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE “ACT”) AND MAY NOT BE SOLD, OFFERED FOR SALE, TRANSFERRED, PLEDGED OR HYPOTHECATED WITHOUT
REGISTRATION UNDER THE ACT UNLESS EITHER (i) THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL, IN FORM AND SUBSTANCE REASONABLY
SATISFACTORY TO THE COMPANY, TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED IN CONNECTION WITH SUCH DISPOSITION OR (ii) THE
SALE OF SUCH SECURITIES IS MADE PURSUANT TO RULE 144 PROMULGATED UNDER THE ACT.

	Date
    of Issuance: February 10, 2021	 	Void
    after: February 10, 2026

 

WARRANT
TO PURCHASE COMMON STOCK

of

NEUROPATHIX,
INC.

This
Warrant to Purchase Common Stock of Neuropathix, Inc. (this “Warrant”), is issued to Lyons Capital LLC (and,
together with its permitted successors and assigns, the “Holder”) by Neuropathix, Inc., a Delaware corporation
(the “Company”). This Warrant is issued as part of a series of similar warrants (the “Warrants”)
issued to the Holder.

Purchase
of Shares.

Number
of Shares. Subject to the terms and conditions set forth herein, in consideration for the Holder purchasing 3,500,000 shares
of the Company’s common stock, pursuant to the terms and conditions as set forth in that certain Common Stock Purchase Agreement,
dated as of even date herewith, by and between the Holder and the Company (the “Agreement”), the Holder is
entitled, upon surrender of this Warrant at the principal office of the Company (or at such other place as the Company shall notify
the Holder in writing), to purchase from the Company 1,750,000 fully paid and nonassessable shares of the Company’s common
stock (the “Common Stock”).

Exercise
Price. The exercise price for the shares of Common Stock issuable pursuant to Section 1(a) of this Warrant (the “Warrant
Shares”) shall be $0.22 per share (the “Exercise Price”). The Warrant Shares and the Exercise Price
shall be subject to adjustment pursuant to Section 8 hereof.

Exercise
Period. This Warrant shall be exercisable beginning on the date of this Warrant and ending at 5:00 p.m. Eastern Standard Time
on the five (5) year anniversary of the date hereof (the “Exercise Period”); provided, however, that
this Warrant shall no longer be exercisable and become null and void upon the consummation of a Change of Control. In the event
of a Change of Control, the Company shall notify the Holder at least ten (10) days prior to the consummation of such Change of
Control. For the purposes hereof, a “Change of Control” shall mean (i) the direct or indirect sale or transfer,
in a single transaction or a series of related transactions, by the stockholders of the Company of voting securities, in which
the holders of the outstanding voting securities of the Company immediately prior to such transaction or series of transactions
hold, as a result of holding Company securities prior to such transaction, in the aggregate, securities possessing less than fifty
percent (50%) of the total combined voting power of all outstanding voting securities of the Company or of the acquiring entity
immediately after such transaction or series of related transactions; (ii) a merger or consolidation in which the Company is not
the surviving entity, except for a transaction in which the holders of the outstanding voting securities of the Company immediately
prior to such merger or consolidation hold as a result of holding Company securities prior to such transaction, in the aggregate,
securities possessing more than fifty percent (50%) of the total combined voting power of all outstanding voting securities of
the surviving entity (or the parent of the surviving entity) immediately after such merger or consolidation; (iii) a reverse merger
in which the Company is the surviving entity but in which the holders of the outstanding voting securities of the Company immediately
prior to such merger hold as a result of holding Company securities prior to such transaction, in the aggregate, securities possessing
less than fifty percent (50%) of the total combined voting power of all outstanding voting securities of the Company or of the
acquiring entity immediately after such merger; or (iv) the sale, transfer or other disposition (in one transaction or a series
of related transactions) of all or substantially all of the assets of the Company, except for a transaction in which the holders
of the outstanding voting securities of the Company immediately prior to such transaction(s) receive as a distribution with respect
to securities of the Company, in the aggregate, securities possessing more than fifty percent (50%) of the total combined voting
power of all outstanding voting securities of the acquiring entity immediately after such transaction(s). Notwithstanding the
foregoing or anything herein contained to the contrary, the following shall not be deemed to constitute a Change in Control: (A)
a merger effected exclusively for the purpose of changing the domicile of the Company; or (B) a transaction or series of related
transactions in which the stockholders of the Company immediately following such transaction or series of related transactions
own 50% or less of the voting power of the Company if such transactions were undertaken wholly or primarily for capital raising
purposes.

Method
of Exercise.

While
this Warrant remains outstanding and exercisable in accordance with Section 2 above, the Holder may exercise, in whole or in part,
the purchase rights evidenced hereby. Such exercise shall be effected by:

the
surrender of the Warrant, together with a duly executed copy of the Notice of Exercise attached hereto, to the Secretary of the
Company at its principal office (or at such other place as the Company shall notify the Holder in writing); and

the
payment in cash to the Company of an amount equal to the aggregate Exercise Price for the number of Warrant Shares being purchased.

Each
exercise of this Warrant shall be deemed to have been effected immediately prior to the close of business on the day on which
this Warrant is surrendered to the Company as provided in Section 3(a) above. At such time, the person or persons in whose name
or names any certificate for the Warrant Shares shall be issuable upon such exercise as provided in Section 3(c) below shall be
deemed to have become the holder or holders of record of the Warrant Shares represented by such certificate.

As
soon as practicable after the exercise of this Warrant in whole or in part, the Company at its expense will cause to be issued
in the name of, and delivered to, the Holder, or as such Holder (upon payment by such Holder of any applicable transfer taxes)
may direct:

a
certificate or certificates for the number of Warrant Shares to which such Holder shall be entitled, and

in
case such exercise is in part only, a new warrant or warrants (dated the date hereof) of like tenor, calling in the aggregate
on the face or faces thereof for the number of Warrant Shares equal to the number of such Warrant Shares described in this Warrant
minus the number of such Warrant Shares purchased by the Holder upon all exercises made in accordance with Section 3(a) above.

Piggyback
Registration Rights. Whenever the Company proposes to register any of its securities under the Act, as amended (other than
pursuant to a registration primarily for sales of securities to employees of the Company under Form S-8 or pursuant to a business
combination under Form S-4), the Company will include in such registration all Warrants and Warrant Shares held by the Holder.

Warranties
and Covenants of the Company. 

In
connection with the transactions provided for herein, the Company hereby represents and warrants to the Holder that the Warrant
Shares, when issued, sold, and delivered in accordance with the terms of the Warrants for the consideration expressed therein,
will be (i) duly and validly issued, fully paid and nonassessable, (ii) free from all taxes, liens and charges with respect to
the issuance thereof, and (iii) based in part upon the representations and warranties of the Holder in this Warrant, will be issued
in compliance with all applicable federal and state securities laws.

The
Company covenants and agrees that the Company will at all times during the Exercise Period, have authorized and reserved a sufficient
number of shares of its Common Stock to provide for the exercise of the rights represented by this Warrant. If at any time during
the Exercise Period the number of authorized but unissued shares of the Company’s Common Stock shall not be sufficient to
permit exercise of this Warrant, the Company will take such corporate action as may, in the opinion of its counsel, be necessary
to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purposes.

In
the event of any taking by the Company of a record of the holders of any class of securities for the purpose of determining the
holders thereof who are entitled to receive any dividend or other distribution, the Company shall mail to the Holder, at least
10 days prior to the date of such record, a notice specifying the date on which such record is to be taken for the purpose of
such dividend or distribution.

Representations
and Warranties of the Holder. In connection with the transactions provided for herein, the Holder hereby represents and warrants
to the Company that:

Authorization.
Holder represents that it has full power and authority to enter into this Warrant. This Warrant constitutes the Holder’s
valid and legally binding obligation, enforceable in accordance with its terms, except as may be limited by (i) applicable bankruptcy,
insolvency, reorganization, or similar laws relating to or affecting the enforcement of creditors’ rights and (ii) laws
relating to the availability of specific performance, injunctive relief or other equitable remedies.

Purchase
Entirely for Own Account. The Holder acknowledges that this Warrant is entered into by the Holder in reliance upon such Holder’s
representation to the Company that the Warrant and the Warrant Shares (collectively, the “Securities”) will
be acquired for investment for the Holder’s own account, not as a nominee or agent, and not with a view to the resale or
distribution of any part thereof, and that the Holder has no present intention of selling, granting any participation in or otherwise
distributing the same. By acknowledging this Warrant, the Holder further represents that the Holder does not have any contract,
undertaking, agreement, or arrangement with any person to sell, transfer or grant participations to such person or to any third
person, with respect to the Securities.

Disclosure
of Information. The Holder acknowledges that it has received all the information it considers necessary or appropriate for
deciding whether to acquire the Securities. The Holder further represents that it has had an opportunity to ask questions and
receive answers from the Company regarding the terms and conditions of the offering of the Securities.

Investment
Experience. The Holder acknowledges that it is able to fend for itself, can bear the economic risk of its investment, and
has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of the
investment in the Securities. If other than an individual, the Holder also represents it has not been organized solely for the
purpose of acquiring the Securities.

Accredited
Investor. The Holder is an “accredited investor” within the meaning of Rule 501 of Regulation D, as presently
in effect, as promulgated by the Securities and Exchange Commission (the “SEC”) under the Act.

Restricted
Securities. The Holder understands that the Securities are characterized as “restricted securities” under the
federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering
and that under such laws and applicable regulations such securities may be resold without registration under the Act, only in
certain limited circumstances. In this connection, each Holder represents that it is familiar with Rule 144, as presently in effect,
as promulgated by the SEC under the Act (“Rule 144”), and understands the resale limitations imposed thereby
and by the Act.

Further
Limitations on Disposition. Without in any way limiting the representations set forth above, the Holder further agrees not
to make any disposition of all or any portion of the Warrant Shares unless and until the transferee has agreed in writing for
the benefit of the Company to be bound by the terms of this Warrant, including, without limitation, this Section 6, Section 19,
and:

there
is then in effect a registration statement under the Act covering such proposed disposition and such disposition is made in accordance
with such registration statement; or

the
Holder shall have notified the Company of the proposed disposition and shall have furnished the Company with a detailed statement
of the circumstances surrounding the proposed disposition, and if reasonably requested by the Company, the Holder shall have furnished
the Company with an opinion of counsel, reasonably satisfactory to the Company, that such disposition will not require registration
of such shares under the Act. It is agreed that the Company will not require opinions of counsel for transactions made pursuant
to Rule 144 except in extraordinary circumstances.

Legends.
It is understood that the Securities may bear the following legend, or substantially similar legends:

“THE
SECURITIES REPRESENTED HEREBY HAVE BEEN ISSUED WITHOUT REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
AND MAY NOT BE SOLD, OFFERED FOR SALE, TRANSFERRED, PLEDGED OR HYPOTHECATED WITHOUT REGISTRATION UNDER THE ACT UNLESS EITHER (i) THE
COMPANY HAS RECEIVED AN OPINION OF COUNSEL, IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE COMPANY, TO THE EFFECT THAT REGISTRATION
IS NOT REQUIRED IN CONNECTION WITH SUCH DISPOSITION OR (ii) THE SALE OF SUCH SECURITIES IS MADE PURSUANT TO RULE 144 PROMULGATED
UNDER THE ACT.”

1. 
Maximum Exercise. The Holder shall not be entitled to exercise this Warrant on an exercise date, in connection with that
number of shares of Common Stock which would be in excess of the sum of (i) the number of shares of Common Stock beneficially
owned by the Holder and its affiliates on an exercise date, and (ii) the number of shares of Common Stock issuable upon the exercise
of this Warrant with respect to which the determination of this limitation is being made on an exercise date, which would result
in beneficial ownership by the Holder and its affiliates of more than 4.99% of the outstanding shares of Common Stock on such
date. For the purposes of the immediately preceding sentence, beneficial ownership shall be determined in accordance with Section
13(d) of the Securities Exchange Act of 1934, as amended, and Rule 13d-3 thereunder.

Adjustment
of Exercise Price and Number of Shares. The number and kind of Warrant Shares purchasable upon exercise of this Warrant and
the Exercise Price shall be subject to adjustment from time to time as follows:

Subdivisions,
Combinations and Other Issuances. If the Company shall at any time after the issuance but prior to the expiration of this
Warrant subdivide its Common Stock, by split-up or otherwise, or combine its Common Stock, or issue additional shares of its Common
Stock or Common Stock as a dividend with respect to any shares of its Common Stock, the number of Warrant Shares issuable on the
exercise of this Warrant shall forthwith be proportionately increased in the case of a subdivision or stock dividend, or proportionately
decreased in the case of a combination. Appropriate adjustments shall also be made to the Exercise Price payable per share, but
the aggregate Exercise Price payable for the total number of Warrant Shares purchasable under this Warrant (as adjusted) shall
remain the same. Any adjustment under this Section 8(a) shall become effective at the close of business on the date the subdivision
or combination becomes effective, or as of the record date of such dividend, or in the event that no record date is fixed, upon
the making of such dividend.

Reclassification,
Reorganization and Consolidation. In case of any reclassification, capital reorganization or change in the capital stock of
the Company (other than as a result of a subdivision, combination or stock dividend provided for in Section 8(a) above), then,
as a condition of such reclassification, reorganization or change, lawful provision shall be made, and duly executed documents
evidencing the same from the Company or its successor shall be delivered to the Holder, so that the Holder shall have the right
at any time prior to the expiration of this Warrant to purchase, at a total price equal to that payable upon the exercise of this
Warrant, the kind and amount of shares of stock and other securities or property receivable in connection with such reclassification,
reorganization or change by a holder of the same number and type of securities as were purchasable as Warrant Shares by the Holder
immediately prior to such reclassification, reorganization or change. In any such case appropriate provisions shall be made with
respect to the rights and interest of the Holder so that the provisions hereof shall thereafter be applicable with respect to
any shares of stock or other securities or property deliverable upon exercise hereof, and appropriate adjustments shall be made
to the Exercise Price per Share payable hereunder, provided the aggregate Exercise Price shall remain the same.

Notice
of Adjustment. When any adjustment is required to be made in the number or kind of shares purchasable upon exercise of the
Warrant, or in the Exercise Price, the Company shall promptly notify the Holder of such event and of the number of Warrant Shares
or other securities or property thereafter purchasable upon exercise of this Warrant.

Conversion
of Common Stock. In the event that all outstanding shares of Common Stock are converted to any other security, this Warrant
shall become exercisable for such other security.

No
Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant, but in lieu of such fractional shares the Company shall round up to the nearest whole share.

No
Stockholder Rights. Prior to exercise of this Warrant, the Holder shall not be entitled to any rights of a stockholder with
respect to the Warrant Shares, including (without limitation) the right to vote such Warrant Shares, receive dividends or other
distributions thereon, exercise preemptive rights or be notified of stockholder meetings, and, except as otherwise provided in
this Warrant, such Holder shall not be entitled to any stockholder notice or other communication concerning the business or affairs
of the Company.

Governing
Law; Venue. This Warrant shall be governed by and construed under the laws of the State of Pennsylvania as applied to agreements
among Pennsylvania residents, made and to be performed entirely within the State of Pennsylvania. The parties agree that any dispute
arising in connection with the interpretation or validity of, or otherwise arising out of, this Warrant, will be subject to the
exclusive jurisdiction of the Pennsylvania State and Federal Courts in and for Bucks County, Pennsylvania. The parties hereby
agree to submit to the personal and exclusive jurisdiction and venue of such courts and agree that process may be served in the
manner provided herein for the giving of notices or otherwise as allowed by applicable law. Each party hereto waives any defense
of inconvenient forum to the maintenance of any action so brought and waives any bond, surety, or other security that might be
required of any other party with respect thereto.

Successors
and Assigns. The terms and provisions of this Warrant shall inure to the benefit of, and be binding upon, the Company and
the holders hereof and their respective successors and permitted assigns.

Titles
and Subtitles. The titles and subtitles used in this Warrant are used for convenience only and are not to be considered in
construing or interpreting this Warrant.

Notices.
All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed effectively given:
(a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during
normal business hours of the recipient, and if not so confirmed, then on the next business day, (c) five (5) days after having
been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a
nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications
shall be sent to the respective parties at addresses set forth on the signature pages hereto (or at such other addresses as shall
be specified by notice given in accordance with this Section 14).

Expenses.
If any action at law or in equity is necessary to enforce or interpret the terms of this Warrant, the prevailing party shall be
entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such
party may be entitled.

2. 
Entire Agreement. This Warrant constitutes the entire agreement of the parties with regard to the subject matter hereof
and supersedes any and all prior negotiations, correspondence, understandings and agreements among the parties regarding the subject
matter hereof, whether oral or written.

Amendments;
Waivers. Any term of this Warrant may be amended and the observance of any term of this Warrant may be waived (either generally
or in a particular instance and either retroactively or prospectively) only with the written consent of, or a written instrument
signed by (i) the Company, and (ii) Holder.

Loss
or Mutilation. Upon receipt of evidence reasonably satisfactory to the Company of the ownership of and the loss, theft, destruction
or mutilation of this Warrant, and of indemnity reasonably satisfactory to it, and (in the case of mutilation) upon surrender
and cancellation of this Warrant, the Company will execute and deliver in lieu thereof a new Warrant of like tenor as the lost,
stolen, destroyed or mutilated Warrant.

Severability.
If any provision of this Warrant is held to be unenforceable under applicable law, such provision shall be excluded from this
Warrant and the balance of the Warrant shall be interpreted as if such provision were so excluded and shall be enforceable in
accordance with its terms.

 

[Remainder
of page intentionally left blank]

    	 	1	 

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Warrant as of the date first written above.

 

	COMPANY:

         

        NEUROPATHIX,
INC.

_______________________________

Dean Petkanas, its CEO

         

         

        Address:

        3805
        Old Easton Road

        Doylestown, PA 18902

        Telephone:
        _____________________

        Facsimile:
        _____________________

        Email:
        ________________________

         
	HOLDER:

         

        LYONS
        CAPITAL LLC

        

        _______________________________

        Jason Lyons, its Chairman

         

         

        Address:

        _______________________________

        _______________________________

        _______________________________

        Telephone:
        _____________________

        Facsimile:
        _____________________

        Email:
        ________________________

         

         

 

 

 

    	 	2	 

     

    

NOTICE
OF EXERCISE

NEUROPATHIX,
INC.

Attention:
Corporate Secretary

The
undersigned hereby elects to purchase, pursuant to the provisions of the Warrant, as follows:

		☐	_____________
                                         shares of Common Stock pursuant to the terms of the attached Warrant, and tenders herewith
                                         payment in cash of the Exercise Price of such Warrant Shares in full, together with all
                                         applicable transfer taxes, if any.

The
undersigned hereby represents and warrants that THE Representations and Warranties in Section 6 hereof are true and correct
as of the date hereof.

	 	 	HOLDER:
	 	 	 
	Date:	 	By:
	 	 	 
	 	 	Address:
	 	 	 
	 	 	 

Name
in which Warrant Shares should be registered:

    	 	3THIS
WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE BEEN AND WILL BE ISSUED WITHOUT REGISTRATION UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE “ACT”) AND MAY NOT BE SOLD, OFFERED FOR SALE, TRANSFERRED, PLEDGED OR HYPOTHECATED WITHOUT
REGISTRATION UNDER THE ACT UNLESS EITHER (i) THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL, IN FORM AND SUBSTANCE REASONABLY
SATISFACTORY TO THE COMPANY, TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED IN CONNECTION WITH SUCH DISPOSITION OR (ii) THE
SALE OF SUCH SECURITIES IS MADE PURSUANT TO RULE 144 PROMULGATED UNDER THE ACT.

	Date
    of Issuance: February 10, 2021	 	Void
    after: February 10, 2026

 

WARRANT
TO PURCHASE COMMON STOCK

of

NEUROPATHIX,
INC.

This
Warrant to Purchase Common Stock of Neuropathix, Inc. (this “Warrant”), is issued to Lyons Capital LLC (and,
together with its permitted successors and assigns, the “Holder”) by Neuropathix, Inc., a Delaware corporation
(the “Company”). This Warrant is issued as part of a series of similar warrants (the “Warrants”)
issued to the Holder.

Purchase
of Shares.

Number
of Shares. Subject to the terms and conditions set forth herein, in consideration for the Holder purchasing 3,500,000 shares
of the Company’s common stock, pursuant to the terms and conditions as set forth in that certain Common Stock Purchase Agreement,
dated as of even date herewith, by and between the Holder and the Company (the “Agreement”), the Holder is
entitled, upon surrender of this Warrant at the principal office of the Company (or at such other place as the Company shall notify
the Holder in writing), to purchase from the Company 1,750,000 fully paid and nonassessable shares of the Company’s common
stock (the “Common Stock”).

Exercise
Price. The exercise price for the shares of Common Stock issuable pursuant to Section 1(a) of this Warrant (the “Warrant
Shares”) shall be $0.27 per share (the “Exercise Price”). The Warrant Shares and the Exercise Price
shall be subject to adjustment pursuant to Section 8 hereof.

Exercise
Period. This Warrant shall be exercisable beginning on the date of this Warrant and ending at 5:00 p.m. Eastern Standard Time
on the five (5) year anniversary of the date hereof (the “Exercise Period”); provided, however, that
this Warrant shall no longer be exercisable and become null and void upon the consummation of a Change of Control. In the event
of a Change of Control, the Company shall notify the Holder at least ten (10) days prior to the consummation of such Change of
Control. For the purposes hereof, a “Change of Control” shall mean (i) the direct or indirect sale or transfer,
in a single transaction or a series of related transactions, by the stockholders of the Company of voting securities, in which
the holders of the outstanding voting securities of the Company immediately prior to such transaction or series of transactions
hold, as a result of holding Company securities prior to such transaction, in the aggregate, securities possessing less than fifty
percent (50%) of the total combined voting power of all outstanding voting securities of the Company or of the acquiring entity
immediately after such transaction or series of related transactions; (ii) a merger or consolidation in which the Company is not
the surviving entity, except for a transaction in which the holders of the outstanding voting securities of the Company immediately
prior to such merger or consolidation hold as a result of holding Company securities prior to such transaction, in the aggregate,
securities possessing more than fifty percent (50%) of the total combined voting power of all outstanding voting securities of
the surviving entity (or the parent of the surviving entity) immediately after such merger or consolidation; (iii) a reverse merger
in which the Company is the surviving entity but in which the holders of the outstanding voting securities of the Company immediately
prior to such merger hold as a result of holding Company securities prior to such transaction, in the aggregate, securities possessing
less than fifty percent (50%) of the total combined voting power of all outstanding voting securities of the Company or of the
acquiring entity immediately after such merger; or (iv) the sale, transfer or other disposition (in one transaction or a series
of related transactions) of all or substantially all of the assets of the Company, except for a transaction in which the holders
of the outstanding voting securities of the Company immediately prior to such transaction(s) receive as a distribution with respect
to securities of the Company, in the aggregate, securities possessing more than fifty percent (50%) of the total combined voting
power of all outstanding voting securities of the acquiring entity immediately after such transaction(s). Notwithstanding the
foregoing or anything herein contained to the contrary, the following shall not be deemed to constitute a Change in Control: (A)
a merger effected exclusively for the purpose of changing the domicile of the Company; or (B) a transaction or series of related
transactions in which the stockholders of the Company immediately following such transaction or series of related transactions
own 50% or less of the voting power of the Company if such transactions were undertaken wholly or primarily for capital raising
purposes.

Method
of Exercise.

While
this Warrant remains outstanding and exercisable in accordance with Section 2 above, the Holder may exercise, in whole or in part,
the purchase rights evidenced hereby. Such exercise shall be effected by:

the
surrender of the Warrant, together with a duly executed copy of the Notice of Exercise attached hereto, to the Secretary of the
Company at its principal office (or at such other place as the Company shall notify the Holder in writing); and

the
payment in cash to the Company of an amount equal to the aggregate Exercise Price for the number of Warrant Shares being purchased.

Each
exercise of this Warrant shall be deemed to have been effected immediately prior to the close of business on the day on which
this Warrant is surrendered to the Company as provided in Section 3(a) above. At such time, the person or persons in whose name
or names any certificate for the Warrant Shares shall be issuable upon such exercise as provided in Section 3(c) below shall be
deemed to have become the holder or holders of record of the Warrant Shares represented by such certificate.

As
soon as practicable after the exercise of this Warrant in whole or in part, the Company at its expense will cause to be issued
in the name of, and delivered to, the Holder, or as such Holder (upon payment by such Holder of any applicable transfer taxes)
may direct:

a
certificate or certificates for the number of Warrant Shares to which such Holder shall be entitled, and

in
case such exercise is in part only, a new warrant or warrants (dated the date hereof) of like tenor, calling in the aggregate
on the face or faces thereof for the number of Warrant Shares equal to the number of such Warrant Shares described in this Warrant
minus the number of such Warrant Shares purchased by the Holder upon all exercises made in accordance with Section 3(a) above.

Piggyback
Registration Rights. Whenever the Company proposes to register any of its securities under the Act, as amended (other than
pursuant to a registration primarily for sales of securities to employees of the Company under Form S-8 or pursuant to a business
combination under Form S-4), the Company will include in such registration all Warrants and Warrant Shares held by the Holder.

Warranties
and Covenants of the Company. 

In
connection with the transactions provided for herein, the Company hereby represents and warrants to the Holder that the Warrant
Shares, when issued, sold, and delivered in accordance with the terms of the Warrants for the consideration expressed therein,
will be (i) duly and validly issued, fully paid and nonassessable, (ii) free from all taxes, liens and charges with respect to
the issuance thereof, and (iii) based in part upon the representations and warranties of the Holder in this Warrant, will be issued
in compliance with all applicable federal and state securities laws.

The
Company covenants and agrees that the Company will at all times during the Exercise Period, have authorized and reserved a sufficient
number of shares of its Common Stock to provide for the exercise of the rights represented by this Warrant. If at any time during
the Exercise Period the number of authorized but unissued shares of the Company’s Common Stock shall not be sufficient to
permit exercise of this Warrant, the Company will take such corporate action as may, in the opinion of its counsel, be necessary
to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purposes.

In
the event of any taking by the Company of a record of the holders of any class of securities for the purpose of determining the
holders thereof who are entitled to receive any dividend or other distribution, the Company shall mail to the Holder, at least
10 days prior to the date of such record, a notice specifying the date on which such record is to be taken for the purpose of
such dividend or distribution.

Representations
and Warranties of the Holder. In connection with the transactions provided for herein, the Holder hereby represents and warrants
to the Company that:

Authorization.
Holder represents that it has full power and authority to enter into this Warrant. This Warrant constitutes the Holder’s
valid and legally binding obligation, enforceable in accordance with its terms, except as may be limited by (i) applicable bankruptcy,
insolvency, reorganization, or similar laws relating to or affecting the enforcement of creditors’ rights and (ii) laws
relating to the availability of specific performance, injunctive relief or other equitable remedies.

Purchase
Entirely for Own Account. The Holder acknowledges that this Warrant is entered into by the Holder in reliance upon such Holder’s
representation to the Company that the Warrant and the Warrant Shares (collectively, the “Securities”) will
be acquired for investment for the Holder’s own account, not as a nominee or agent, and not with a view to the resale or
distribution of any part thereof, and that the Holder has no present intention of selling, granting any participation in or otherwise
distributing the same. By acknowledging this Warrant, the Holder further represents that the Holder does not have any contract,
undertaking, agreement, or arrangement with any person to sell, transfer or grant participations to such person or to any third
person, with respect to the Securities.

Disclosure
of Information. The Holder acknowledges that it has received all the information it considers necessary or appropriate for
deciding whether to acquire the Securities. The Holder further represents that it has had an opportunity to ask questions and
receive answers from the Company regarding the terms and conditions of the offering of the Securities.

Investment
Experience. The Holder acknowledges that it is able to fend for itself, can bear the economic risk of its investment, and
has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of the
investment in the Securities. If other than an individual, the Holder also represents it has not been organized solely for the
purpose of acquiring the Securities.

Accredited
Investor. The Holder is an “accredited investor” within the meaning of Rule 501 of Regulation D, as presently
in effect, as promulgated by the Securities and Exchange Commission (the “SEC”) under the Act.

Restricted
Securities. The Holder understands that the Securities are characterized as “restricted securities” under the
federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering
and that under such laws and applicable regulations such securities may be resold without registration under the Act, only in
certain limited circumstances. In this connection, each Holder represents that it is familiar with Rule 144, as presently in effect,
as promulgated by the SEC under the Act (“Rule 144”), and understands the resale limitations imposed thereby
and by the Act.

Further
Limitations on Disposition. Without in any way limiting the representations set forth above, the Holder further agrees not
to make any disposition of all or any portion of the Warrant Shares unless and until the transferee has agreed in writing for
the benefit of the Company to be bound by the terms of this Warrant, including, without limitation, this Section 6, Section 19,
and:

there
is then in effect a registration statement under the Act covering such proposed disposition and such disposition is made in accordance
with such registration statement; or

the
Holder shall have notified the Company of the proposed disposition and shall have furnished the Company with a detailed statement
of the circumstances surrounding the proposed disposition, and if reasonably requested by the Company, the Holder shall have furnished
the Company with an opinion of counsel, reasonably satisfactory to the Company, that such disposition will not require registration
of such shares under the Act. It is agreed that the Company will not require opinions of counsel for transactions made pursuant
to Rule 144 except in extraordinary circumstances.

Legends.
It is understood that the Securities may bear the following legend, or substantially similar legends:

“THE
SECURITIES REPRESENTED HEREBY HAVE BEEN ISSUED WITHOUT REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
AND MAY NOT BE SOLD, OFFERED FOR SALE, TRANSFERRED, PLEDGED OR HYPOTHECATED WITHOUT REGISTRATION UNDER THE ACT UNLESS EITHER (i) THE
COMPANY HAS RECEIVED AN OPINION OF COUNSEL, IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE COMPANY, TO THE EFFECT THAT REGISTRATION
IS NOT REQUIRED IN CONNECTION WITH SUCH DISPOSITION OR (ii) THE SALE OF SUCH SECURITIES IS MADE PURSUANT TO RULE 144 PROMULGATED
UNDER THE ACT.”

1. 
Maximum Exercise. The Holder shall not be entitled to exercise this Warrant on an exercise date, in connection with that
number of shares of Common Stock which would be in excess of the sum of (i) the number of shares of Common Stock beneficially
owned by the Holder and its affiliates on an exercise date, and (ii) the number of shares of Common Stock issuable upon the exercise
of this Warrant with respect to which the determination of this limitation is being made on an exercise date, which would result
in beneficial ownership by the Holder and its affiliates of more than 4.99% of the outstanding shares of Common Stock on such
date. For the purposes of the immediately preceding sentence, beneficial ownership shall be determined in accordance with Section
13(d) of the Securities Exchange Act of 1934, as amended, and Rule 13d-3 thereunder.

Adjustment
of Exercise Price and Number of Shares. The number and kind of Warrant Shares purchasable upon exercise of this Warrant and
the Exercise Price shall be subject to adjustment from time to time as follows:

Subdivisions,
Combinations and Other Issuances. If the Company shall at any time after the issuance but prior to the expiration of this
Warrant subdivide its Common Stock, by split-up or otherwise, or combine its Common Stock, or issue additional shares of its Common
Stock or Common Stock as a dividend with respect to any shares of its Common Stock, the number of Warrant Shares issuable on the
exercise of this Warrant shall forthwith be proportionately increased in the case of a subdivision or stock dividend, or proportionately
decreased in the case of a combination. Appropriate adjustments shall also be made to the Exercise Price payable per share, but
the aggregate Exercise Price payable for the total number of Warrant Shares purchasable under this Warrant (as adjusted) shall
remain the same. Any adjustment under this Section 8(a) shall become effective at the close of business on the date the subdivision
or combination becomes effective, or as of the record date of such dividend, or in the event that no record date is fixed, upon
the making of such dividend.

Reclassification,
Reorganization and Consolidation. In case of any reclassification, capital reorganization or change in the capital stock of
the Company (other than as a result of a subdivision, combination or stock dividend provided for in Section 8(a) above), then,
as a condition of such reclassification, reorganization or change, lawful provision shall be made, and duly executed documents
evidencing the same from the Company or its successor shall be delivered to the Holder, so that the Holder shall have the right
at any time prior to the expiration of this Warrant to purchase, at a total price equal to that payable upon the exercise of this
Warrant, the kind and amount of shares of stock and other securities or property receivable in connection with such reclassification,
reorganization or change by a holder of the same number and type of securities as were purchasable as Warrant Shares by the Holder
immediately prior to such reclassification, reorganization or change. In any such case appropriate provisions shall be made with
respect to the rights and interest of the Holder so that the provisions hereof shall thereafter be applicable with respect to
any shares of stock or other securities or property deliverable upon exercise hereof, and appropriate adjustments shall be made
to the Exercise Price per Share payable hereunder, provided the aggregate Exercise Price shall remain the same.

Notice
of Adjustment. When any adjustment is required to be made in the number or kind of shares purchasable upon exercise of the
Warrant, or in the Exercise Price, the Company shall promptly notify the Holder of such event and of the number of Warrant Shares
or other securities or property thereafter purchasable upon exercise of this Warrant.

Conversion
of Common Stock. In the event that all outstanding shares of Common Stock are converted to any other security, this Warrant
shall become exercisable for such other security.

No
Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant, but in lieu of such fractional shares the Company shall round up to the nearest whole share.

No
Stockholder Rights. Prior to exercise of this Warrant, the Holder shall not be entitled to any rights of a stockholder with
respect to the Warrant Shares, including (without limitation) the right to vote such Warrant Shares, receive dividends or other
distributions thereon, exercise preemptive rights or be notified of stockholder meetings, and, except as otherwise provided in
this Warrant, such Holder shall not be entitled to any stockholder notice or other communication concerning the business or affairs
of the Company.

Governing
Law; Venue. This Warrant shall be governed by and construed under the laws of the State of Pennsylvania as applied to agreements
among Pennsylvania residents, made and to be performed entirely within the State of Pennsylvania. The parties agree that any dispute
arising in connection with the interpretation or validity of, or otherwise arising out of, this Warrant, will be subject to the
exclusive jurisdiction of the Pennsylvania State and Federal Courts in and for Bucks County, Pennsylvania. The parties hereby
agree to submit to the personal and exclusive jurisdiction and venue of such courts and agree that process may be served in the
manner provided herein for the giving of notices or otherwise as allowed by applicable law. Each party hereto waives any defense
of inconvenient forum to the maintenance of any action so brought and waives any bond, surety, or other security that might be
required of any other party with respect thereto.

Successors
and Assigns. The terms and provisions of this Warrant shall inure to the benefit of, and be binding upon, the Company and
the holders hereof and their respective successors and permitted assigns.

Titles
and Subtitles. The titles and subtitles used in this Warrant are used for convenience only and are not to be considered in
construing or interpreting this Warrant.

Notices.
All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed effectively given:
(a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during
normal business hours of the recipient, and if not so confirmed, then on the next business day, (c) five (5) days after having
been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a
nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications
shall be sent to the respective parties at addresses set forth on the signature pages hereto (or at such other addresses as shall
be specified by notice given in accordance with this Section 14).

Expenses.
If any action at law or in equity is necessary to enforce or interpret the terms of this Warrant, the prevailing party shall be
entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such
party may be entitled.

2. 
Entire Agreement. This Warrant constitutes the entire agreement of the parties with regard to the subject matter hereof
and supersedes any and all prior negotiations, correspondence, understandings and agreements among the parties regarding the subject
matter hereof, whether oral or written.

Amendments;
Waivers. Any term of this Warrant may be amended and the observance of any term of this Warrant may be waived (either generally
or in a particular instance and either retroactively or prospectively) only with the written consent of, or a written instrument
signed by (i) the Company, and (ii) Holder.

Loss
or Mutilation. Upon receipt of evidence reasonably satisfactory to the Company of the ownership of and the loss, theft, destruction
or mutilation of this Warrant, and of indemnity reasonably satisfactory to it, and (in the case of mutilation) upon surrender
and cancellation of this Warrant, the Company will execute and deliver in lieu thereof a new Warrant of like tenor as the lost,
stolen, destroyed or mutilated Warrant.

Severability.
If any provision of this Warrant is held to be unenforceable under applicable law, such provision shall be excluded from this
Warrant and the balance of the Warrant shall be interpreted as if such provision were so excluded and shall be enforceable in
accordance with its terms.

 

[Remainder
of page intentionally left blank]

    	 	1	 

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Warrant as of the date first written above.

 

	COMPANY:

         

        NEUROPATHIX,
        INC.

        

        _______________________________

        Dean Petkanas, its CEO

         

         

        Address:

        3805
        Old Easton Road

        Doylestown, PA 18902

        Telephone:
        _____________________

        Facsimile:
        _____________________

        Email:
        ________________________

         
	HOLDER:

         

        LYONS
        CAPITAL LLC

        

        _______________________________

        Jason Lyons, its Chairman

         

         

        Address:

        _______________________________

        _______________________________

        _______________________________

        Telephone:
        _____________________

        Facsimile:
        _____________________

        Email:
        ________________________

         

         

 

 

    	 	2	 

     

    

NOTICE
OF EXERCISE

NEUROPATHIX,
INC.

Attention:
Corporate Secretary

The
undersigned hereby elects to purchase, pursuant to the provisions of the Warrant, as follows:

		q	_____________
                                         shares of Common Stock pursuant to the terms of the attached Warrant, and tenders herewith
                                         payment in cash of the Exercise Price of such Warrant Shares in full, together with all
                                         applicable transfer taxes, if any.

The
undersigned hereby represents and warrants that THE Representations and Warranties in Section 6 hereof are true and correct
as of the date hereof.

	 	 	HOLDER:
	 	 	 
	Date:	 	By:
	 	 	 
	 	 	Address:
	 	 	 
	 	 	 

Name
in which Warrant Shares should be registered:

    	 	3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}]]